Technology Opportunity Showcase highlights
some unique technologies that NASA has developed and which we believe
have strong potential for commercial application. While the descriptions
provided here are brief, they should provide enough information
to communicate the potential applications of the technology. For
more detailed information, contact the person listed. Please mention
that you read about it in Innovation.
|
Technology Opportunity Showcase
Biological Fluids Technology
Optical Diagnostics of Biological Fluids and Tissues
NASA is seeking companies interested in commercializing a technology
for studying and characterizing various biological fluids. A fiber-optic
dynamic light scattering (DLS) probe has been developed at NASA's
Lewis Research Center to study various biological fluids--a formidable
challenge to the designers of optical diagnostics instrumentation
because these fluids often contain a wide range of particulate matter.
Conventional DLS is routinely used to characterize dilute macromolecular
solutions in an effective size range of 3 nanometers to 3 millimeters.
The fiber optic DLS probe developed by Lewis surpasses the bulkiness,
poor sensitivity, long processing periods, and high-power and safety
requirements of conventional DLS. The probe's compact system exploits
the principles of DLS and offers a fast means of quantitatively
and noninvasively characterizing various biological fluids, such
as protein solutions, blood, viruses, spermatozoa and synovial fluids.
It can also be used for single-angle static light-scattering measurements
and analysis of skin and tissue. The benefits of this technology
are that it is compact and portable, has flexible in-situ and in-vivo
applications, offers low laser power (10 nanowatts to 3 milliwatts)
and fast measurement time (5 to 30 seconds) and is equipped with
a miniaturized microscope for visualizing macroscopic particles.
For more information, contact Dr. Rafat Ansari at Lewis Research
Center.
Call: 216/433-5008, E-mail: Rafat.R.Ansari@lerc.nasa.gov
Please mention you read about it in Innovation.
Preservative Coated Salivettes
NASA is seeking commercial applications of its Preservative Coated
Salivettes (PCS), which allow for the storage of saliva samples
in liquid form, at room temperature, for six months or longer. When
a saliva sample is taken, the vial is centrifuged. This forces the
saliva from the sample swab to the bottom of the vial, where a preservative
coating dissolves in the saliva. This preserves the saliva sample
for up to six months. The PCS technology has potential uses in environmental
sampling of water or chemicals, which require preserved samples
or later analysis. The technology could be modified for the purpose
of storing other biological samples, and it could be used for saliva
sampling in remote locations and/or foreign markets. PCS doubles
the shelf life of samples, reduces the costs related to refrigerated
transportation and storage and allows extended storage capability
without degradation to saliva samples. It could improve current
screening processes for AIDS, hepatitis, measles and other diseases.
For more information, contact Dr. Lakshmi Putcha at Johnson Space
Center.
Call: 281/483-7760, E-mail: lakshmi.putcha1@jsc.nasa.gov Please
mention you read about it in Innovation.
Whole Blood Staining Device
The Whole Blood Staining Device is a handheld, self-contained
device that provides a means to stain white blood cells by using
monoclonal antibodies conjugated to various fluorochromes, followed
by lysing and fixing the cells using a diluted commercial reagent.
It also provides a means to store whole blood safely in a refrigerator
for up to 72 hours before processing and analysis. The Whole Blood
Staining Device consists of a reagent tube, an injection site and
two external clips. Potential markets are health care, government
and military medical testing, as well as National Institutes of
Health and Center for Disease Control testing in remote locations
or sites established to provide "outpost" operations for
medical service and the treatment of disease. Small hospitals can
also benefit by purchasing this single device, rather than buying
expensive lysing equipment, large stocks of monoclonal-antibody
reagents and a flow cytometer. It can be used to test the efficacy
of therapeutic regimes, such as drug protocol in the treatment of
AIDS or prenuptial screening for genetic traits for couples desiring
to have children. The Whole Blood Staining Device does not require
power, precise mixing or incubation. It is inexpensive and easy
to manufacture. The prototype of the technology is available at
NASA's Johnson Space Center, and units are being manufactured for
NASA use under government contract.
For more information, contact Dr. Clarence Sams at Johnson Space
Center.
Call: 281/483-7160, E-mail: clarence.sams1@jsc.nasa.gov
Please mention you read about it in Innovation.
|